Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals
Novel coronavirus disease 2019 is rapidly spreading throughout the New York metropolitan area since its first reported case on March 1, 2020. The state is now the epicenter of coronavirus disease 2019 outbreak in the United States, with 84,735 cases reported as of April 2, 2020. We previously presen...
Gespeichert in:
Veröffentlicht in: | American journal of obstetrics & gynecology MFM 2020-05, Vol.2 (2), p.100118-100118, Article 100118 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 100118 |
---|---|
container_issue | 2 |
container_start_page | 100118 |
container_title | American journal of obstetrics & gynecology MFM |
container_volume | 2 |
creator | Breslin, Noelle Baptiste, Caitlin Gyamfi-Bannerman, Cynthia Miller, Russell Martinez, Rebecca Bernstein, Kyra Ring, Laurence Landau, Ruth Purisch, Stephanie Friedman, Alexander M. Fuchs, Karin Sutton, Desmond Andrikopoulou, Maria Rupley, Devon Sheen, Jean-Ju Aubey, Janice Zork, Noelia Moroz, Leslie Mourad, Mirella Wapner, Ronald Simpson, Lynn L. D’Alton, Mary E. Goffman, Dena |
description | Novel coronavirus disease 2019 is rapidly spreading throughout the New York metropolitan area since its first reported case on March 1, 2020. The state is now the epicenter of coronavirus disease 2019 outbreak in the United States, with 84,735 cases reported as of April 2, 2020. We previously presented an early case series with 7 coronavirus disease 2019–positive pregnant patients, 2 of whom were diagnosed with coronavirus disease 2019 after an initial asymptomatic presentation. We now describe a series of 43 test-positive cases of coronavirus disease 2019 presenting to an affiliated pair of New York City hospitals for more than 2 weeks, from March 13, 2020, to March 27, 2020. A total of 14 patients (32.6%) presented without any coronavirus disease 2019–associated viral symptoms and were identified after they developed symptoms during admission or after the implementation of universal testing for all obstetric admissions on March 22. Among them, 10 patients (71.4%) developed symptoms of coronavirus disease 2019 over the course of their delivery admission or early after postpartum discharge. Of the other 29 patients (67.4%) who presented with symptomatic coronavirus disease 2019, 3 women ultimately required antenatal admission for viral symptoms, and another patient re-presented with worsening respiratory status requiring oxygen supplementation 6 days postpartum after a successful labor induction. There were no confirmed cases of coronavirus disease 2019 detected in neonates upon initial testing on the first day of life. Based on coronavirus disease 2019 disease severity characteristics by Wu and McGoogan, 37 women (86%) exhibited mild disease, 4 (9.3%) severe disease, and 2 (4.7%) critical disease; these percentages are similar to those described in nonpregnant adults with coronavirus disease 2019 (about 80% mild, 15% severe, and 5% critical disease). |
doi_str_mv | 10.1016/j.ajogmf.2020.100118 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7144599</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2589933320300483</els_id><sourcerecordid>2390165121</sourcerecordid><originalsourceid>FETCH-LOGICAL-c580t-df987dfb18691b6ee19e9a450b66af92edd8b73215b15969dc3ee0aa572718913</originalsourceid><addsrcrecordid>eNp9kU1vEzEQhlcIRKvSf4CQj1wSbG_2wxyQUFQ-pAoucOBkzdrj1OmuZ7GdRPlN_El2lVLChdPYnpn3Hc9TFC8FXwou6jfbJWxpM7il5HJ-4kK0T4pLWbVqocqyfHp2viiuU9pyzqVYrSpZPy8uSimVVLy8LH6tKVKAvY-7xKxPCAmZ5EIxHxya7CkwGChsGKTjMGYaIHvDIFh2fh8jbgKEzA40YHjL8oHYAfE-MXLMUHA-DmjnsoQhwyybWKZJh4FzvveQ5zT4ODd8wQP7QfGerX0-sjtKo8_QpxfFMzcFvH6IV8X3Dzff1p8Wt18_fl6_v12YquV5YZ1qG-s60dZKdDWiUKhgVfGursEpida2XVNKUXWiUrWypkTkAFUjG9EqUV4V7066466bpjbTxBF6PUY_QDxqAq__zQR_pze01828YKUmgdcPApF-7jBlPfhksO8hIO2SlqWaIFZCzl6rU6mJlFJE92gjuJ5R660-odYzan1CPbW9Oh_xsekP2L9_wGlRe49RJ-MxGLQ-Tli1Jf9_h99uKcDk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2390165121</pqid></control><display><type>article</type><title>Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Breslin, Noelle ; Baptiste, Caitlin ; Gyamfi-Bannerman, Cynthia ; Miller, Russell ; Martinez, Rebecca ; Bernstein, Kyra ; Ring, Laurence ; Landau, Ruth ; Purisch, Stephanie ; Friedman, Alexander M. ; Fuchs, Karin ; Sutton, Desmond ; Andrikopoulou, Maria ; Rupley, Devon ; Sheen, Jean-Ju ; Aubey, Janice ; Zork, Noelia ; Moroz, Leslie ; Mourad, Mirella ; Wapner, Ronald ; Simpson, Lynn L. ; D’Alton, Mary E. ; Goffman, Dena</creator><creatorcontrib>Breslin, Noelle ; Baptiste, Caitlin ; Gyamfi-Bannerman, Cynthia ; Miller, Russell ; Martinez, Rebecca ; Bernstein, Kyra ; Ring, Laurence ; Landau, Ruth ; Purisch, Stephanie ; Friedman, Alexander M. ; Fuchs, Karin ; Sutton, Desmond ; Andrikopoulou, Maria ; Rupley, Devon ; Sheen, Jean-Ju ; Aubey, Janice ; Zork, Noelia ; Moroz, Leslie ; Mourad, Mirella ; Wapner, Ronald ; Simpson, Lynn L. ; D’Alton, Mary E. ; Goffman, Dena</creatorcontrib><description>Novel coronavirus disease 2019 is rapidly spreading throughout the New York metropolitan area since its first reported case on March 1, 2020. The state is now the epicenter of coronavirus disease 2019 outbreak in the United States, with 84,735 cases reported as of April 2, 2020. We previously presented an early case series with 7 coronavirus disease 2019–positive pregnant patients, 2 of whom were diagnosed with coronavirus disease 2019 after an initial asymptomatic presentation. We now describe a series of 43 test-positive cases of coronavirus disease 2019 presenting to an affiliated pair of New York City hospitals for more than 2 weeks, from March 13, 2020, to March 27, 2020. A total of 14 patients (32.6%) presented without any coronavirus disease 2019–associated viral symptoms and were identified after they developed symptoms during admission or after the implementation of universal testing for all obstetric admissions on March 22. Among them, 10 patients (71.4%) developed symptoms of coronavirus disease 2019 over the course of their delivery admission or early after postpartum discharge. Of the other 29 patients (67.4%) who presented with symptomatic coronavirus disease 2019, 3 women ultimately required antenatal admission for viral symptoms, and another patient re-presented with worsening respiratory status requiring oxygen supplementation 6 days postpartum after a successful labor induction. There were no confirmed cases of coronavirus disease 2019 detected in neonates upon initial testing on the first day of life. Based on coronavirus disease 2019 disease severity characteristics by Wu and McGoogan, 37 women (86%) exhibited mild disease, 4 (9.3%) severe disease, and 2 (4.7%) critical disease; these percentages are similar to those described in nonpregnant adults with coronavirus disease 2019 (about 80% mild, 15% severe, and 5% critical disease).</description><identifier>ISSN: 2589-9333</identifier><identifier>EISSN: 2589-9333</identifier><identifier>DOI: 10.1016/j.ajogmf.2020.100118</identifier><identifier>PMID: 32292903</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Ambulatory Care ; Anti-Bacterial Agents - therapeutic use ; Asymptomatic Diseases ; Azithromycin - therapeutic use ; Carrier State - diagnosis ; Cesarean Section ; COVID-19 ; COVID-19 - complications ; COVID-19 - diagnosis ; COVID-19 - physiopathology ; COVID-19 - therapy ; COVID-19 Nucleic Acid Testing ; Disease Management ; Enzyme Inhibitors - therapeutic use ; Female ; Fluid Therapy ; Gestational Age ; Hospitalization ; Hospitals, Community ; Hospitals, University ; Humans ; Hydroxychloroquine - therapeutic use ; Infection Control - methods ; Intensive Care Units ; Labor, Induced ; Labor, Obstetric ; Multi-Institutional Systems ; New York City ; novel coronavirus ; Obesity, Maternal - complications ; Obstetric Labor, Premature ; Oxygen Inhalation Therapy ; Pregnancy ; Pregnancy Complications, Infectious - diagnosis ; Pregnancy Complications, Infectious - physiopathology ; Pregnancy Complications, Infectious - therapy ; Retrospective Studies ; SARS-CoV-2 ; Telemedicine ; Young Adult</subject><ispartof>American journal of obstetrics & gynecology MFM, 2020-05, Vol.2 (2), p.100118-100118, Article 100118</ispartof><rights>2020 Elsevier Inc.</rights><rights>2020 Elsevier Inc. All rights reserved.</rights><rights>2020 Elsevier Inc. All rights reserved. 2020 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c580t-df987dfb18691b6ee19e9a450b66af92edd8b73215b15969dc3ee0aa572718913</citedby><cites>FETCH-LOGICAL-c580t-df987dfb18691b6ee19e9a450b66af92edd8b73215b15969dc3ee0aa572718913</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32292903$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Breslin, Noelle</creatorcontrib><creatorcontrib>Baptiste, Caitlin</creatorcontrib><creatorcontrib>Gyamfi-Bannerman, Cynthia</creatorcontrib><creatorcontrib>Miller, Russell</creatorcontrib><creatorcontrib>Martinez, Rebecca</creatorcontrib><creatorcontrib>Bernstein, Kyra</creatorcontrib><creatorcontrib>Ring, Laurence</creatorcontrib><creatorcontrib>Landau, Ruth</creatorcontrib><creatorcontrib>Purisch, Stephanie</creatorcontrib><creatorcontrib>Friedman, Alexander M.</creatorcontrib><creatorcontrib>Fuchs, Karin</creatorcontrib><creatorcontrib>Sutton, Desmond</creatorcontrib><creatorcontrib>Andrikopoulou, Maria</creatorcontrib><creatorcontrib>Rupley, Devon</creatorcontrib><creatorcontrib>Sheen, Jean-Ju</creatorcontrib><creatorcontrib>Aubey, Janice</creatorcontrib><creatorcontrib>Zork, Noelia</creatorcontrib><creatorcontrib>Moroz, Leslie</creatorcontrib><creatorcontrib>Mourad, Mirella</creatorcontrib><creatorcontrib>Wapner, Ronald</creatorcontrib><creatorcontrib>Simpson, Lynn L.</creatorcontrib><creatorcontrib>D’Alton, Mary E.</creatorcontrib><creatorcontrib>Goffman, Dena</creatorcontrib><title>Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals</title><title>American journal of obstetrics & gynecology MFM</title><addtitle>Am J Obstet Gynecol MFM</addtitle><description>Novel coronavirus disease 2019 is rapidly spreading throughout the New York metropolitan area since its first reported case on March 1, 2020. The state is now the epicenter of coronavirus disease 2019 outbreak in the United States, with 84,735 cases reported as of April 2, 2020. We previously presented an early case series with 7 coronavirus disease 2019–positive pregnant patients, 2 of whom were diagnosed with coronavirus disease 2019 after an initial asymptomatic presentation. We now describe a series of 43 test-positive cases of coronavirus disease 2019 presenting to an affiliated pair of New York City hospitals for more than 2 weeks, from March 13, 2020, to March 27, 2020. A total of 14 patients (32.6%) presented without any coronavirus disease 2019–associated viral symptoms and were identified after they developed symptoms during admission or after the implementation of universal testing for all obstetric admissions on March 22. Among them, 10 patients (71.4%) developed symptoms of coronavirus disease 2019 over the course of their delivery admission or early after postpartum discharge. Of the other 29 patients (67.4%) who presented with symptomatic coronavirus disease 2019, 3 women ultimately required antenatal admission for viral symptoms, and another patient re-presented with worsening respiratory status requiring oxygen supplementation 6 days postpartum after a successful labor induction. There were no confirmed cases of coronavirus disease 2019 detected in neonates upon initial testing on the first day of life. Based on coronavirus disease 2019 disease severity characteristics by Wu and McGoogan, 37 women (86%) exhibited mild disease, 4 (9.3%) severe disease, and 2 (4.7%) critical disease; these percentages are similar to those described in nonpregnant adults with coronavirus disease 2019 (about 80% mild, 15% severe, and 5% critical disease).</description><subject>Adult</subject><subject>Ambulatory Care</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Asymptomatic Diseases</subject><subject>Azithromycin - therapeutic use</subject><subject>Carrier State - diagnosis</subject><subject>Cesarean Section</subject><subject>COVID-19</subject><subject>COVID-19 - complications</subject><subject>COVID-19 - diagnosis</subject><subject>COVID-19 - physiopathology</subject><subject>COVID-19 - therapy</subject><subject>COVID-19 Nucleic Acid Testing</subject><subject>Disease Management</subject><subject>Enzyme Inhibitors - therapeutic use</subject><subject>Female</subject><subject>Fluid Therapy</subject><subject>Gestational Age</subject><subject>Hospitalization</subject><subject>Hospitals, Community</subject><subject>Hospitals, University</subject><subject>Humans</subject><subject>Hydroxychloroquine - therapeutic use</subject><subject>Infection Control - methods</subject><subject>Intensive Care Units</subject><subject>Labor, Induced</subject><subject>Labor, Obstetric</subject><subject>Multi-Institutional Systems</subject><subject>New York City</subject><subject>novel coronavirus</subject><subject>Obesity, Maternal - complications</subject><subject>Obstetric Labor, Premature</subject><subject>Oxygen Inhalation Therapy</subject><subject>Pregnancy</subject><subject>Pregnancy Complications, Infectious - diagnosis</subject><subject>Pregnancy Complications, Infectious - physiopathology</subject><subject>Pregnancy Complications, Infectious - therapy</subject><subject>Retrospective Studies</subject><subject>SARS-CoV-2</subject><subject>Telemedicine</subject><subject>Young Adult</subject><issn>2589-9333</issn><issn>2589-9333</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU1vEzEQhlcIRKvSf4CQj1wSbG_2wxyQUFQ-pAoucOBkzdrj1OmuZ7GdRPlN_El2lVLChdPYnpn3Hc9TFC8FXwou6jfbJWxpM7il5HJ-4kK0T4pLWbVqocqyfHp2viiuU9pyzqVYrSpZPy8uSimVVLy8LH6tKVKAvY-7xKxPCAmZ5EIxHxya7CkwGChsGKTjMGYaIHvDIFh2fh8jbgKEzA40YHjL8oHYAfE-MXLMUHA-DmjnsoQhwyybWKZJh4FzvveQ5zT4ODd8wQP7QfGerX0-sjtKo8_QpxfFMzcFvH6IV8X3Dzff1p8Wt18_fl6_v12YquV5YZ1qG-s60dZKdDWiUKhgVfGursEpida2XVNKUXWiUrWypkTkAFUjG9EqUV4V7066466bpjbTxBF6PUY_QDxqAq__zQR_pze01828YKUmgdcPApF-7jBlPfhksO8hIO2SlqWaIFZCzl6rU6mJlFJE92gjuJ5R660-odYzan1CPbW9Oh_xsekP2L9_wGlRe49RJ-MxGLQ-Tli1Jf9_h99uKcDk</recordid><startdate>20200501</startdate><enddate>20200501</enddate><creator>Breslin, Noelle</creator><creator>Baptiste, Caitlin</creator><creator>Gyamfi-Bannerman, Cynthia</creator><creator>Miller, Russell</creator><creator>Martinez, Rebecca</creator><creator>Bernstein, Kyra</creator><creator>Ring, Laurence</creator><creator>Landau, Ruth</creator><creator>Purisch, Stephanie</creator><creator>Friedman, Alexander M.</creator><creator>Fuchs, Karin</creator><creator>Sutton, Desmond</creator><creator>Andrikopoulou, Maria</creator><creator>Rupley, Devon</creator><creator>Sheen, Jean-Ju</creator><creator>Aubey, Janice</creator><creator>Zork, Noelia</creator><creator>Moroz, Leslie</creator><creator>Mourad, Mirella</creator><creator>Wapner, Ronald</creator><creator>Simpson, Lynn L.</creator><creator>D’Alton, Mary E.</creator><creator>Goffman, Dena</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200501</creationdate><title>Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals</title><author>Breslin, Noelle ; Baptiste, Caitlin ; Gyamfi-Bannerman, Cynthia ; Miller, Russell ; Martinez, Rebecca ; Bernstein, Kyra ; Ring, Laurence ; Landau, Ruth ; Purisch, Stephanie ; Friedman, Alexander M. ; Fuchs, Karin ; Sutton, Desmond ; Andrikopoulou, Maria ; Rupley, Devon ; Sheen, Jean-Ju ; Aubey, Janice ; Zork, Noelia ; Moroz, Leslie ; Mourad, Mirella ; Wapner, Ronald ; Simpson, Lynn L. ; D’Alton, Mary E. ; Goffman, Dena</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c580t-df987dfb18691b6ee19e9a450b66af92edd8b73215b15969dc3ee0aa572718913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Ambulatory Care</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Asymptomatic Diseases</topic><topic>Azithromycin - therapeutic use</topic><topic>Carrier State - diagnosis</topic><topic>Cesarean Section</topic><topic>COVID-19</topic><topic>COVID-19 - complications</topic><topic>COVID-19 - diagnosis</topic><topic>COVID-19 - physiopathology</topic><topic>COVID-19 - therapy</topic><topic>COVID-19 Nucleic Acid Testing</topic><topic>Disease Management</topic><topic>Enzyme Inhibitors - therapeutic use</topic><topic>Female</topic><topic>Fluid Therapy</topic><topic>Gestational Age</topic><topic>Hospitalization</topic><topic>Hospitals, Community</topic><topic>Hospitals, University</topic><topic>Humans</topic><topic>Hydroxychloroquine - therapeutic use</topic><topic>Infection Control - methods</topic><topic>Intensive Care Units</topic><topic>Labor, Induced</topic><topic>Labor, Obstetric</topic><topic>Multi-Institutional Systems</topic><topic>New York City</topic><topic>novel coronavirus</topic><topic>Obesity, Maternal - complications</topic><topic>Obstetric Labor, Premature</topic><topic>Oxygen Inhalation Therapy</topic><topic>Pregnancy</topic><topic>Pregnancy Complications, Infectious - diagnosis</topic><topic>Pregnancy Complications, Infectious - physiopathology</topic><topic>Pregnancy Complications, Infectious - therapy</topic><topic>Retrospective Studies</topic><topic>SARS-CoV-2</topic><topic>Telemedicine</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Breslin, Noelle</creatorcontrib><creatorcontrib>Baptiste, Caitlin</creatorcontrib><creatorcontrib>Gyamfi-Bannerman, Cynthia</creatorcontrib><creatorcontrib>Miller, Russell</creatorcontrib><creatorcontrib>Martinez, Rebecca</creatorcontrib><creatorcontrib>Bernstein, Kyra</creatorcontrib><creatorcontrib>Ring, Laurence</creatorcontrib><creatorcontrib>Landau, Ruth</creatorcontrib><creatorcontrib>Purisch, Stephanie</creatorcontrib><creatorcontrib>Friedman, Alexander M.</creatorcontrib><creatorcontrib>Fuchs, Karin</creatorcontrib><creatorcontrib>Sutton, Desmond</creatorcontrib><creatorcontrib>Andrikopoulou, Maria</creatorcontrib><creatorcontrib>Rupley, Devon</creatorcontrib><creatorcontrib>Sheen, Jean-Ju</creatorcontrib><creatorcontrib>Aubey, Janice</creatorcontrib><creatorcontrib>Zork, Noelia</creatorcontrib><creatorcontrib>Moroz, Leslie</creatorcontrib><creatorcontrib>Mourad, Mirella</creatorcontrib><creatorcontrib>Wapner, Ronald</creatorcontrib><creatorcontrib>Simpson, Lynn L.</creatorcontrib><creatorcontrib>D’Alton, Mary E.</creatorcontrib><creatorcontrib>Goffman, Dena</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of obstetrics & gynecology MFM</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Breslin, Noelle</au><au>Baptiste, Caitlin</au><au>Gyamfi-Bannerman, Cynthia</au><au>Miller, Russell</au><au>Martinez, Rebecca</au><au>Bernstein, Kyra</au><au>Ring, Laurence</au><au>Landau, Ruth</au><au>Purisch, Stephanie</au><au>Friedman, Alexander M.</au><au>Fuchs, Karin</au><au>Sutton, Desmond</au><au>Andrikopoulou, Maria</au><au>Rupley, Devon</au><au>Sheen, Jean-Ju</au><au>Aubey, Janice</au><au>Zork, Noelia</au><au>Moroz, Leslie</au><au>Mourad, Mirella</au><au>Wapner, Ronald</au><au>Simpson, Lynn L.</au><au>D’Alton, Mary E.</au><au>Goffman, Dena</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals</atitle><jtitle>American journal of obstetrics & gynecology MFM</jtitle><addtitle>Am J Obstet Gynecol MFM</addtitle><date>2020-05-01</date><risdate>2020</risdate><volume>2</volume><issue>2</issue><spage>100118</spage><epage>100118</epage><pages>100118-100118</pages><artnum>100118</artnum><issn>2589-9333</issn><eissn>2589-9333</eissn><abstract>Novel coronavirus disease 2019 is rapidly spreading throughout the New York metropolitan area since its first reported case on March 1, 2020. The state is now the epicenter of coronavirus disease 2019 outbreak in the United States, with 84,735 cases reported as of April 2, 2020. We previously presented an early case series with 7 coronavirus disease 2019–positive pregnant patients, 2 of whom were diagnosed with coronavirus disease 2019 after an initial asymptomatic presentation. We now describe a series of 43 test-positive cases of coronavirus disease 2019 presenting to an affiliated pair of New York City hospitals for more than 2 weeks, from March 13, 2020, to March 27, 2020. A total of 14 patients (32.6%) presented without any coronavirus disease 2019–associated viral symptoms and were identified after they developed symptoms during admission or after the implementation of universal testing for all obstetric admissions on March 22. Among them, 10 patients (71.4%) developed symptoms of coronavirus disease 2019 over the course of their delivery admission or early after postpartum discharge. Of the other 29 patients (67.4%) who presented with symptomatic coronavirus disease 2019, 3 women ultimately required antenatal admission for viral symptoms, and another patient re-presented with worsening respiratory status requiring oxygen supplementation 6 days postpartum after a successful labor induction. There were no confirmed cases of coronavirus disease 2019 detected in neonates upon initial testing on the first day of life. Based on coronavirus disease 2019 disease severity characteristics by Wu and McGoogan, 37 women (86%) exhibited mild disease, 4 (9.3%) severe disease, and 2 (4.7%) critical disease; these percentages are similar to those described in nonpregnant adults with coronavirus disease 2019 (about 80% mild, 15% severe, and 5% critical disease).</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32292903</pmid><doi>10.1016/j.ajogmf.2020.100118</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2589-9333 |
ispartof | American journal of obstetrics & gynecology MFM, 2020-05, Vol.2 (2), p.100118-100118, Article 100118 |
issn | 2589-9333 2589-9333 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7144599 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Adult Ambulatory Care Anti-Bacterial Agents - therapeutic use Asymptomatic Diseases Azithromycin - therapeutic use Carrier State - diagnosis Cesarean Section COVID-19 COVID-19 - complications COVID-19 - diagnosis COVID-19 - physiopathology COVID-19 - therapy COVID-19 Nucleic Acid Testing Disease Management Enzyme Inhibitors - therapeutic use Female Fluid Therapy Gestational Age Hospitalization Hospitals, Community Hospitals, University Humans Hydroxychloroquine - therapeutic use Infection Control - methods Intensive Care Units Labor, Induced Labor, Obstetric Multi-Institutional Systems New York City novel coronavirus Obesity, Maternal - complications Obstetric Labor, Premature Oxygen Inhalation Therapy Pregnancy Pregnancy Complications, Infectious - diagnosis Pregnancy Complications, Infectious - physiopathology Pregnancy Complications, Infectious - therapy Retrospective Studies SARS-CoV-2 Telemedicine Young Adult |
title | Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T02%3A49%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Coronavirus%20disease%202019%20infection%20among%20asymptomatic%20and%20symptomatic%20pregnant%20women:%20two%20weeks%20of%20confirmed%20presentations%20to%20an%20affiliated%20pair%20of%20New%20York%20City%20hospitals&rft.jtitle=American%20journal%20of%20obstetrics%20&%20gynecology%20MFM&rft.au=Breslin,%20Noelle&rft.date=2020-05-01&rft.volume=2&rft.issue=2&rft.spage=100118&rft.epage=100118&rft.pages=100118-100118&rft.artnum=100118&rft.issn=2589-9333&rft.eissn=2589-9333&rft_id=info:doi/10.1016/j.ajogmf.2020.100118&rft_dat=%3Cproquest_pubme%3E2390165121%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2390165121&rft_id=info:pmid/32292903&rft_els_id=S2589933320300483&rfr_iscdi=true |